Results 141 to 150 of about 1,626,687 (308)

Joint optimization of opportunistic maintenance and speed control for continuous process manufacturing systems considering stochastic imperfect maintenance

Computers & industrial engineering
Zhao-Xiang Chen, Zhen Chen, Di Zhou, E. Pan   +3 more
semanticscholar   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Streamlining oversight in Medicare advantage: measuring coding intensity via contract rankings. [PDF]

Health Aff Sch
Chang T, Qiu M, Hu Z, Zapzalka D, Shanmugam DM, Shenfeld DK, Parikh RB, Makar M, Emanuel EJ, Brown Z, Kowalski AE, Wiens J.   +11 more
europepmc   +1 more source

Condition-based and age-based maintenance in a multi-component system with heterogeneous components incorporating imperfect preventive maintenance actions

Computers & industrial engineering
L. Bautista, I. Castro, M. D. Di Nardo, T. Murino   +3 more
semanticscholar   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Risk prevention and control evaluation and optimization strategy for digital transformation in oil and gas production management areas. [PDF]

Sci Rep
Chen X, Jiang D, Wu J, Huang Y, Gao D, Huang R.   +5 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Ecological continuity in sustainable higher education under SDG 4.7: a process model of participation competence. [PDF]

Front Psychol
Wang M, Guo Y.
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Patient-specific subperiosteal implants for oral and maxillofacial rehabilitation: a narrative review of current evidence, clinical decision-making, and unresolved questions. [PDF]

Int J Implant Dent
Al-Nawas B, Bär AK, Kwon YD.
europepmc   +1 more source